3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
20
Neoplasm Metastasis
8
Leukemia, Myeloid, Acute
7
Skin Neoplasms
6
Ovarian Neoplasms
6
Lymphoma, Non-Hodgkin
6
Colorectal Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Leukemia, Lymphocytic, Chronic, B-Cell
5
Uveal Melanoma
4
Stomach Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Triple Negative Breast Neoplasms
3
Recurrence
3
Rectal Neoplasms
3
Pancreatic Neoplasms
3
Mesothelioma, Malignant
3
Lymphoma, Follicular
3
Lymphoma
3
Lung Neoplasms
3
Leukemia
3
Esophageal Neoplasms
3
Carcinoma, Renal Cell
3
Uterine Cervical Neoplasms
2
Sarcoma
2
Pleural Effusion, Malignant
2
Neuroblastoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Interventions
Cyclophosphamide
3
regorafenib
2
Proton Therapy
2
Methods
2
Gemcitabine
2
Doxorubicin
2
tocilizumab
1
poly ICLC
1
pembrolizumab
1
liposomal doxorubicin
1
lenvatinib
1
fludarabine
1
flt3 ligand protein
1
endostar protein
1
alectinib
1
aldesleukin
1
Weight-Bearing
1
Transcranial Direct Current Stimulation
1
Taxes
1
Surveys and Questionnaires
1
Standard of Care
1
Restraint, Physical
1
Range of Motion, Articular
1
Radiotherapy
1
Radiosurgery
1
Radiation
1
Quality of Life
1
Psychology, Positive
1
Platinum
1
Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Bone Neoplasms
×
Interleukin-2
×
1 year
×
Clear all
No trials found.